IHC-SALL4 Test, Price, Normal Range | Sprint Diagnostics Hyderabad

The test is performed on a tissue sample, usually obtained through a biopsy. The sample is treated with antibodies that bind to the SALL4 protein. If the protein is present, it can be detected under a microscope.

No, fasting is not necessary for this test.

No specific preparations are necessary for this test.

The IHC-SALL4 test is typically ordered by your healthcare provider if there is a suspicion of a condition such as a germ cell tumor or acute myeloid leukemia.

A positive result indicates the presence of the SALL4 protein in the tissue sample, supporting the diagnosis of certain conditions. A negative result means that the SALL4 protein was not detected in the tissue sample.

The frequency of this test will be determined by your healthcare provider based on your individual health status and potential risk factors.

No specific precautions are needed for this test. However, it's important to discuss the results with your healthcare provider to understand what they mean for your health.

Technical issues or errors during the biopsy or testing procedure could potentially affect the results. However, these instances are rare.

A positive test result should be discussed with the healthcare provider who ordered the test. They can provide information on what this means for your health and suggest appropriate next steps, which may include a referral to a specialist, such as an oncologist.

Yes, the IHC-SALL4 test can be used for both diagnosis of conditions and for monitoring the effectiveness of treatment.

Yes, the IHC-SALL4 test can be performed on individuals of any age, including children. However, the necessity and appropriateness of this test would be determined by a healthcare provider.

The IHC-SALL4 test is generally safe and poses minimal risks. However, as it involves a biopsy, there might be some risks associated with the biopsy procedure itself, such as bleeding or infection.

While uncommon, false positive or negative results can occur due to technical issues or errors during the testing procedure. Therefore, test results are often considered alongside other diagnostic information.

Whether or not the IHC-SALL4 test can be performed during pregnancy would depend on the individual's health status and the necessity of the test. This decision should be made in consultation with a healthcare provider.

The type of tissue sample needed for the IHC-SALL4 test depends on the suspected location of the disease. For example, a tumor biopsy might be taken if a germ cell tumor is suspected, or a bone marrow sample could be collected if acute myeloid leukemia is being considered.

A positive IHC-SALL4 result indicates the presence of the SALL4 protein in the tissue sample, which may suggest certain diseases, such as germ cell tumors or acute myeloid leukemia. However, the test alone is not enough for a definitive diagnosis, and further diagnostic procedures may be required.

There are no known medications that interfere with the IHC-SALL4 test. However, it's always important to discuss all medications and supplements you're currently taking with your healthcare provider prior to any medical testing.

The IHC-SALL4 test is a reliable diagnostic tool when used in conjunction with other tests and clinical findings. However, a single test should never be used as the sole basis for a diagnosis. A healthcare provider will interpret the test results in the context of the overall clinical picture.

The IHC-SALL4 test detects the presence of SALL4 protein, a substance produced by certain types of cells, regardless of lifestyle factors. However, maintaining a healthy lifestyle is always beneficial for overall health and well-being.